Ultragenyx Pharmaceutical...

NASDAQ: RARE · Real-Time Price · USD
36.84
-0.30 (-0.81%)
At close: Jun 23, 2025, 3:59 PM
37.47
1.72%
Pre-market: Jun 24, 2025, 07:45 AM EDT
-0.81%
Bid 37
Market Cap 3.48B
Revenue (ttm) 590.69M
Net Income (ttm) -549.58M
EPS (ttm) -5.83
PE Ratio (ttm) -6.32
Forward PE -11.13
Analyst Buy
Ask 40
Volume 579,140
Avg. Volume (20D) 1,020,938
Open 36.82
Previous Close 37.14
Day's Range 36.30 - 37.41
52-Week Range 29.59 - 60.37
Beta 0.24

About RARE

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RARE
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RARE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Ultragenyx Pharmaceutical Inc. is scheduled to release its earnings on Jul 31, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-4.68%
RARE stock has given up its prior gain. Ultragenyx... Unlock content with Pro Subscription
1 month ago
-4.68%
Ultragenyx Pharmaceutical shares are trading higher after the company reported better-than-expected Q1 EPS results.